在心力衰竭中开发和验证混合静脉氧和的非侵入性模型
Adam K McDiarmid1, Bradley S Chambers2, David A Broadbent3
1Freeman Hospital, Newcastle Hospitals NHS Trust, Newcastle, United Kingdom; Biosciences Institute, Newcastle University, Newcastle, United Kingdom.
JACC. Advances
|January 29, 2026
概括
心血管磁共振 (CMR) 现在可以非侵入性地估计混合静脉氧和度 (SvO2). 这种成像衍生的SvO2 (iSvO2) 准确预测心力衰竭患者的死亡率和住院治疗.
科学领域:
- 心血管成像 - 心血管成像
- 生物医学工程 生物医学工程
- 临床诊断 临床诊断 临床诊断
背景情况:
- 混合静脉氧和度 (SvO2) 是心力衰竭的关键预后指标,传统上以侵入式方式测量.
- 使用心血管磁共振 (CMR) 的SvO2的非侵入性估计及其预后价值仍然未被探索.
研究的目的:
- 开发一种基于CMR的模型,用于估计混合静脉氧和度 (成像衍生SvO2[iSvO2]).
- 确定开发的iSvO2是否与心力衰竭患者未来的不良事件有关.
主要方法:
- 一个发现队列 (N=30) 与CMR T2映射和右心脏导管治疗被用来通过线性回归来建模iSvO2.
- 628名心力衰竭患者的验证队列接受了CMR和临床评估,并对死亡率和心力衰竭住院进行了随访.
主要成果:
- 在右/左心室血池T2和侵入性SvO2的比率之间发现了强烈的相关性 (R=0.82),产生了方程:iSvO2 = 95·(RV-T2BP/LV-T2BP).
- 在验证队列中,iSvO2强烈预测了主要终点 (全因死亡率或心力衰竭住院) (HR:0.66每10%变化).
- 在调整了多个临床和成像参数后,这种关联仍然显著.
结论:
- 从CMR衍生出的iSvO2使用心室血池的简单T2地图准确估计侵入性SvO2.
- 在现实世界的心力衰竭注册表中,iSvO2 作为死亡率和心力衰竭住院的独立预测器.
相关概念视频
01:19Special considerations while measuring oxygen saturation
967
Assessing respiratory rate concurrently with pulse measurement is fundamental to patient care, providing valuable insights into the patient's respiratory function. The normal breathing rate for an adult usually falls within a normal range of 12 to 20 breaths per minute. Abnormal respiratory rates can signal underlying health conditions or the need for immediate intervention.
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is...
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is...
967
01:29Heart Failure II: Pathophysiology
907
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
907
01:17Pathophysiology of Heart Failure
3.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
01:27Heart Failure I: Introduction
877
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
877
01:22Heart Failure VI: Adjunct Therapies
332
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
332
01:22Heart Failure Drugs: Diuretics
963
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963